Comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190 vs 3q26q27 Microdeletion Syndrome C4755255
Clinical comparison between 3 Phosphoglycerate Dehydrogenase Deficiency and 3q26q27 Microdeletion Syndrome for differential diagnosis and treatment planning.
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
A rare metabolic disorder impairing the body's ability to produce serine, an essential amino acid. It primarily affects the nervous system, causing developmental delay, seizures, and movement difficulties. Management includes serine supplementation and anticonvulsants as needed.
3q26q27 Microdeletion Syndrome C4755255
A genetic disorder from missing genetic material spanning 3q26 to 3q27, associated with developmental delays, growth concerns, and various medical features.
6 comparison axes
Onset
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
0-5
3q26q27 Microdeletion Syndrome C4755255
0-0
Onset patterns differ
Severity
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
severe
3q26q27 Microdeletion Syndrome C4755255
moderate
Different severity levels
Chronic
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
Chronic
3q26q27 Microdeletion Syndrome C4755255
Chronic
Differing course
Communicable
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
No
3q26q27 Microdeletion Syndrome C4755255
No
Different transmission
Body System
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3q26q27 Microdeletion Syndrome C4755255
congenital
Same/different system
Category
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3q26q27 Microdeletion Syndrome C4755255
genetic
Different category
Bottom line
3-phosphoglycerate-dehydrogenase-deficiency-C0580190 and 3q26q27-microdeletion-syndrome-C4755255 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3q26q27 Microdeletion Syndrome C4755255 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a primary neurologic feature of impaired serine production. | Associated with developmental delay from missing 3q26–3q27 material. | Low |
| Seizures | Seizures are a reported neurologic feature; anticonvulsants may be needed. | Seizures are not specifically established by the supplied description. | Moderate |
| Growth concerns | Growth effects are not established in the supplied description. | Growth concerns are specifically associated with the microdeletion. | Moderate |
When to favor each condition
Choose 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 when
Early neurologic illness with seizures and movement difficulty
These features align with the described serine-synthesis disorder, but do not prove it.
Moderate
Metabolic evaluation suggests impaired serine production
A biochemical pattern would support targeted interpretation by a specialist.
Moderate
No chromosomal deletion is identified
A negative genetic study does not exclude this metabolic condition.
Low
Choose 3q26q27 Microdeletion Syndrome C4755255 when
Congenital developmental delay with growth concerns
This pattern fits the supplied microdeletion description better than a metabolic label.
Moderate
Chromosomal testing shows a 3q26–3q27 deletion
A confirmed deletion directly supports the genetic diagnosis.
High
Features are present from birth without a metabolic explanation
Congenital onset favors consideration of the microdeletion, pending testing.
Low
How key tests differ
| Test | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3q26q27 Microdeletion Syndrome C4755255 | Interpretation |
|---|---|---|---|
| Amino acid or serine-pathway studies | May show findings consistent with impaired serine synthesis; exact cutoffs are not supplied. | No characteristic serine abnormality is established. | Abnormal results require specialist confirmation and are not themselves a complete diagnosis. |
| Chromosomal microarray | Not expected to identify this enzyme deficiency. | May detect missing material spanning 3q26 to 3q27. | A detected deletion supports the syndrome; absence does not exclude other diagnoses. |
| Neurologic assessment | May document seizures, developmental delay, or movement difficulty. | May document developmental delay and other variable features. | Clinical findings overlap and cannot reliably separate the conditions alone. |
Prognosis comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
- Outcome
- Described as severe and chronic, but individual outcome is not established.
- Factors
- Neurologic involvement and response to appropriate metabolic and seizure care may matter.
3q26q27 Microdeletion Syndrome C4755255
- Outcome
- Described as moderate and chronic, with variable congenital features.
- Factors
- The deletion's effects and associated medical needs influence outlook.
Time frame: Both are long-term conditions; no reliable timeline is supplied.
Diagnosis confirmation, developmental support, and associated complications require clinician review.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | Developmental delay, seizures, and movement difficulty are described. Developmental delay is described; seizure risk is not established here. The extent and course require individual clinical assessment. |
| Growth problems | Not established from the supplied source. Growth concerns are associated with the syndrome. Do not infer a specific growth pattern without records. |
| Treatment-related burden | Serine supplementation and seizure treatment may be required. Care depends on the individual's variable medical features. No dose, response rate, or outcome should be assumed. |
Patient education highlights
- HighDifferent causes
One condition involves serine metabolism; the other involves missing chromosomal material. Testing distinguishes them.
- HighSpecialist follow-up
Neurology, genetics, and metabolic clinicians should interpret results and coordinate care.
- MediumVariable features
Reported features do not occur uniformly, and many complications are not established by these sources.